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Edited by Felix WielandAbstract Though the role of Hedgehog (Hh) signalling in pat-
terning and diﬀerentiation during development is well established,
the underlying signal transduction mechanisms remain obscure.
This is the ﬁrst report on the overexpression of the human Hh sig-
nalling receptor Smoothened (hSmo) in Saccharomyces cerevi-
siae and Pichia pastoris. We show that hSmo is expressed in
both types of yeast in its native conformational state. The ﬁrst
puriﬁcation presented here will allow the characterisation of
hSmo expressed in yeast, and the scale-up of hSmo production en-
abling structural studies to develop new therapeutic approaches
against tumors and neurodegenerative diseases induced by Hh
signalling dysfunction.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Signalling proteins of the Hedgehog (Hh) family are essen-
tial for patterning and morphogenesis in most multicellular
organisms [1]. Cellular responses to the secreted Hh are medi-
ated by two integral membrane proteins, Patched (Ptc) and
Smoothened (Smo), which were ﬁrst identiﬁed by genetic
screens in Drosophila [2,3]. Activation of the Hh pathway is
triggered by binding of the Hh protein to its receptor PtcAbbreviations: Hh, Hedgehog; hSmo, human Smoothened; Ptc,
Patched; AOX1, alcohol oxidase 1; PMSF, phenylmethylsulfonyl ﬂu-
oride; EGTA, ethylene glycol bis(b-aminoethyl ether); CBD, calmo-
dulin binding domain; HA, hemagglutinin A; PCR, polymerase chain
reaction; SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel
electrophoresis; DDM, n-dodecyl-b-D-maltoside; CHS, cholesteryl
hemisuccinate; CHAPS, 1-propanesulfonate; DDAO, dodecyldim-
ethyl-N-amineoxide
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doi:10.1016/j.febslet.2005.01.054[3,4], thereby alleviating Ptc-mediated suppression of Smo, a
seven-transmembrane protein of the G protein coupled recep-
tors family [5]. Smo activation then triggers a series of intracel-
lular events that result in the expression of Hh target genes
through the Ci/Gli family of transcription factors [6]. Despite
ﬁndings suggesting that Ptc controls Smo function by inﬂuenc-
ing its interactions with small cellular molecules [7,8], and that
Smo directly interacts with a member of the cytoplasmic sig-
nalling complex [9,10], the core mechanism of Smos action re-
mains essentially unknown [11–13]. Moreover, recent studies
suggest that dysfunction of the Hh pathway in stem or precur-
sor cells might contribute to tumorigenenesis and neurodegen-
erative disorders, making the components of this pathway
prime targets for anticancer and antineurodegenerative
therapies [14–16].
Knowing the structure of Hh receptor is essential to under-
stand how this protein functions and how its activity can be
modiﬁed by small molecules, and to elaborate new molecules
able to inhibit or activate it. However, Smo, like the majority
of medically important mammalian membrane proteins, is
present in tissues at very low concentrations, making overex-
pression in heterologous systems a prerequisite for structural
studies [17,18].
We show in the present paper that the Human receptor
Smo can be expressed in its native conformational state in
yeast Saccharomyces cerevisiae and Pichia pastoris, and
puriﬁed.2. Materials and methods
2.1. Construction of expression vectors
For S. cerevisiae, we used the YEpGAL vector containing the
GAL1-10 promotor and the YEpPMA vector containing the plasma
membrane proton ATPase (PMA) promotor, generously given by
Al-Shawi and co-workers [19]. For P. pastoris, we used the pAO815
vector containing the Alcohol oxidase (AOX1) promoter/terminator
cassette (Invitrogen). The Multitag Aﬃnity Puriﬁcation (MAP) se-
quence encoding (i) a factor Xa, a TEV and a thrombin cleavage sites
to eliminate the MAP sequence; (ii) a calmodulin binding domain
(CBD), a streptavidin tag and an hexahistidine tag for aﬃnity chroma-
tography; and (iii) an hemagglutinin peptide (HA) for anti-HA Wes-
tern-blot analysis (Ruel and The´rond, unpublished), was inserted
into the BamHI and XhoI restriction sites of the YEpGAL or YEpP-
MA polylinker, and into the pAO815 EcoRI restriction site, to yield
YEpGAL-MAP, YEpPMA-MAP and pAO815-MAP vectors. PCR
with the Proofstart polymerase (Qiagen) was carried out on the hSmo
cDNA I.M.A.G.E. (Consortium CloneID 4127774 [20]) to introduce atation of European Biochemical Societies.
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nosines, and at the 3 0end an NheI restriction site, using the following
primers: 5 0-ACT AGT TCT AGA GAG CTC CCG CGG AAA
AAA ATG GCC, and 5 0-GGT ACC TCT AGA TCA GCT AGG
GAA GTC CGA GTC TGC. The PCR product was subcloned in
the pCR2.1 plasmid (Invitrogen) and sequenced. HSmo cDNA was
then digested by SpeI and NheI and subcloned in MAP XbaI/NheI
sites, giving PAO815-hSmo-MAP, YEpPMA-hSmo-MAP and
YEpGALhSmo- MAP.
2.2. Yeast strains and media
We used the P. pastoris strain GS115 (his4; [21]) (Invitrogen) and the
S. cerevisiae strain K699 (Mata, ura3, and leu 2-3) generously given by
R. Arkowitz. P. pastoris culture media (RDB plate, Minimal Glycerol
Medium (MGY) and Buﬀered Methanol-Complex Medium (BMMY))
are described in Pichia Expression Kit Manual (Invitrogen). S. cerevi-
siae was grown on minimal medium (MM) (0.67% yeast nitrogen base
without amino acids, 0.1 mM adenine, 0.2 mM uracil and an amino
acid mixture lacking leucine) supplemented with 2% D-glucose, 2%
D-fructose or 2% D-galactose.
2.3. Yeast transformation and culture
P. pastoris was transformed with PAO815-hSmo-MAP or PAO815-
MAP, and cultured 48 h in MGY at 30 C and 220 rpm. Around 6
OD600, cells were centrifuged for 5 min at 430 · g, re-suspended in
BMMY medium at 1 OD600, grown at 30 or 20 C under 220 rpm,
and harvested at diﬀerent times after methanol induction. S. cerevisiae
was transformed with YEpGAL-hSmo-MAP, YEpPMA-hSmo-MAP,
YEpPMA-MAP or YEpGAL-MAP, and grown at 30 or 20 C and
220 rpm on MM supplemented with 2% glucose with YEpPMA vec-
tors, or 2% fructose and diluted to 0.2 OD600 in MM supplemented
with 2% galactose with YEpGAL vectors, until 5 OD600, and centri-
fuged for 10 min at 430 · g and 4 C.
2.4. Crude extract and membrane preparation
All steps were performed at 4 C. Yeast cells were washed in cold
water, re-suspended in disintegration buﬀer (50 mM sodium phosphate
(pH 7.4), 1 mM EDTA, 5% glycerol, freshly added protease inhibitors
cocktail (PIC, Roche), and 1 mM PMSF), and broken by vortexing 1 h
with glass beads (425–600 lm, Sigma). Unbroken yeast were pelleted
for 10 min at 430 · g, and crude extract was obtained from the super-
natant. Membranes were prepared by centrifugation of crude extract
for 1 h at 180000 · g.
2.5. Gel electrophoresis and Western blotting
Protein samples were separated on 10% SDS–PAGE and silver-
stained or transferred to nitrocellulose using standard techniques.
Blots were probed with mouse anti-HA or rabbit anti-Smo (Santa
Cruz Biotechnology), and developed using an ECL kit (Amersham
Biosciences).
2.6. Solubilisation
Eighty micrograms of membranes from S. cerevisiae and P. pastoris
were solubilised in buﬀer A (50 mM Tris–HCl (pH 7.4), 100 mMNaCl,
20% glycerol, PIC, and 1 mM PMSF) plus 1.0% detergent and 0.2%
cholesteryl hemisuccinate (CHS, Sigma) 1 h at 4 C under gentle
agitation.
2.7. Puriﬁcation
All puriﬁcation steps were carried out at 4 C. Ten milligrams of
membranes were stirred for 45 min in 2 ml of buﬀer A plus 1% n-
dodecyl-b-D-maltoside (DDM, Calbiochem) and 0.2% CHS. The sus-
pension was then centrifuged for 1 h at 180000 · g. One-third of the
supernatant was supplemented with 2 mM CaCl2, 1/3 with 10 mM
imidazole and the other 1/3 without addition, and batch loaded dur-
ing 1 h onto 100 ll of calmodulin Sepharose (Amersham), Ni–NTA
agarose (Qiagen) or streptavidin Sepharose (Amersham) pre-equili-
brated. The resin was then centrifuged for 1 min at 400 · g, re-sus-
pended in 1 ml of wash buﬀer (buﬀer A plus 0.1% DDM, 0.02%
CHS, and 2 mM CaCl2, 10 mM imidazole or nothing) and centri-
fuged. This washing step was repeated three times. The resin was
then incubated for 10 min with 100 ll of elution buﬀer (buﬀer A plus
0.1% DDM, 0.02% CHS and 4 mM EGTA for calmodulin sephar-ose, 500 mM imidazole for Ni–NTA agarose or 2 mM biotin for
streptavidin Sepharose), and the eluate was collected after centrifuga-
tion for 1 min at 400 · g. The elution step was also repeated three
times.
2.8. Protein quantiﬁcation
The proteins were quantiﬁed using Bio-Rad protein assay.
2.9. Fluorescence binding assays
For the ﬂow cytometry analysis (FACS Scan; Becton Dickinson),
hSmo-expressing or control yeast cells were incubated overnight at
30 C with 50 nM of BODIPY–cyclopamine (generously given by P.
Beachy [7]), collected by centrifugation, and re-suspended in PBS buf-
fer plus 1% paraformaldehyde. For ﬂuorescence variation measure-
ments (spectroﬂuorimeter SAFAS FLX-Xenius), 200 lg of
membrane fraction with or without hSmo were incubated in PBS
buﬀer and diﬀerent concentrations of BODIPY–cyclopamine (between
0 and 25 nM) 4 h at RT, centrifuged for 1 h at 25,000 · g and re-sus-
pended in 1 ml of PBS buﬀer. The ﬂuorescence variations. DF/F were
calculated for each concentration of cyclopamine (F: membrane ﬂuo-
rescence without cyclopamine, DF: ﬂuorescence intensity diﬀerence be-
tween membranes incubated with cyclopamine and membranes
incubated without cyclopamine). The BODIPY–cyclopamine standard
curve was realised by measuring the ﬂuorescence variations of diﬀerent
BODIPY–cyclopamine concentrations in 1 ml of membranes without
hSmo.3. Results and discussion
3.1. hSmo can be expressed in S. cerevisiae and P. pastoris
Yeast is the simplest eukaryotic cell that performs many of
the post-translational modiﬁcations seen in higher eukaryotic
cells. Moreover, it is easy to grow in large volumes in a short
period of time [22]. S. cerevisiae has been successfully used to
functionally express and purify mammalian membrane pro-
teins such as the human P-glycoprotein [19], the rat vesicular
monoamine transporter [23], and the rabbit SERCA1a Ca2+-
ATPase [24]. With its preference for respiratory growth, the
methylotrophic yeast P. pastoris can be cultured at extremely
high densities [25]. The introduction of heterologous genes at
the AOX1 locus by homologous recombination results in very
high levels of mRNA and protein expression upon methanol
induction [26]. The use of P. pastoris as a heterologous expres-
sion system has been successful for several mammalian integral
membrane proteins such as the ATP-binding cassette trans-
porters [27] and the human dopamine receptor [28]. After
modiﬁcation by PCR to introduce restriction sites and a se-
quence of six adenosines just upstream the ATG initiation co-
don to optimise translation initiation and proteins expression
[29], the hSmo cDNA was subcloned in the expression vectors
at the 5 0-end of the MAP sequence. This MAP sequence fused
at the hSmos C-terminal end provides several epitopes to fol-
low hSmo expression, as well as opportunities for rapid puriﬁ-
cation under mild conditions using several aﬃnity
chromatography columns (Fig. 1). S. cerevisiae transformed
with YEpGAL-hSmo-MAP, YEpPMA-hSmo-MAP,
YEpPMAMAP or YEpGAL-MAP, and P. pastoris trans-
formed with pAO815-hSmo-MAP were screened for expres-
sion of hSmo at the plasma membrane by Western blotting
using antibodies directed against the HA peptides present in
the MAP sequence (anti-HA) or the C-terminal part of Smo
(anti-Smo). We observed that in S. cerevisiae, hSmo is more
expressed at 20 C than at 30 C (data not shown), consistent
with various other studies suggesting that folding and stability
of membrane proteins are often favorably inﬂuenced by low
Fig. 1. MAP sequence fused at hSmo C-terminal end.
M. De Rivoyre et al. / FEBS Letters 579 (2005) 1529–1533 1531temperatures [23]. The hSmo expression decreases after 3
OD600 during the exponential growth, which has also been ob-
served for the human adenosine receptor and explained as a re-
sult of translational or post-translational events [30].
Comparable expression levels were obtained under constitutive
and inducible promoters, and 10% glycerol in growth medium
did not signiﬁcantly enhance hSmo expression, contrary to the
human P-glycoprotein [19]. Fig. 2 shows that hSmo is ex-
pressed in S. cerevisiae membranes as a major protein migrat-
ing around 80 kDa. When higher quantities of membranes are
loaded, we also observe a second band around 110 kDa (Fig.
4B). When grown at 30 C, P. pastoris expressed maximal lev-
els of hSmo in the membrane fraction 24 h after induction with
methanol, and yielded a major signal around 80 kDa and a
weaker signal around 110 kDa (Fig. 2). Lowering the growth
temperature to 20 C did not modify this expression pattern.
The intensities of hSmo detected using anti-HA antibodies
are comparable in S. cerevisiae and P. pastoris membranes
(Fig. 2), suggesting that comparable amounts of hSmo per
mg of membrane proteins are expressed in the two types of
yeast. However, hSmo expressed in S. cerevisiae migrates
slightly faster than hSmo expressed in P. pastoris and is less
immuno-reactive to anti-Smo antibodies. This suggests that
hSmo C-terminal domain may be slightly diﬀerently folded
in S. cerevisiae in comparison to P. pastoris. The molecular
weight calculated from the hSmo sequence is 104 kDa. The
band at 80 kDa being the major product obtained in both
types of yeast, we think that this apparent molecular weight re-
sults from atypical running behaviour of the whole non-glycos-
ylated hSmo. This is frequently observed with membrane
proteins due to their hydrophobicity [28,31], and does not re-
sult from proteolysis. When expressed in COS cells, the mouseFig. 2. hSmo expressed in S. cerevisiae (Sc) and P. pastoris (Pp)
membranes. Western blot with anti-HA antibodies (left) and anti-Smo
antibodies (right) on membrane proteins (20 lg) from YEpPMA-
hSmo-MAP transformed S. cerevisiae grown at 20 C until 2 OD, and
from PAO815-hSmo-MAP transformed P. pastoris induced with
methanol during 24 h at 30 C.Smo is glycosylated and migrates around 110 kDa on SDS–
PAGE gel [7]. The 110 kDa product obtained in yeast could
correspond to a glycosylated form of hSmo. Consistently with
a non-glycosylated form of hSmo, deglycosylation treatment
does not modify the 80 kDa product, but, due to its low
expression level, we did not succeed in obtaining any signiﬁ-
cant result on the 110 kDa product (data not shown).
3.2. hSmo conformational state in S. cerevisiae and P. pastoris
Chen et al. [7] showed that the steroidal alkaloid cyclop-
amine speciﬁcally binds to the mouse Smo heptahelical do-
main, and that this binding is very sensitive to the
conformational state of Smo. As there are 87% of identity be-
tween mSmo and hSmo, we used a ﬂuorescent derivative of
this Smo antagonist (BODIPY–cyclopamine) to investigate
the conformational state of hSmo expressed in yeast. After
incubation with 50 nM of BODIPY–cyclopamine, hSmo-Fig. 3. Cyclopamine ﬂuorescent derivative binding. (A) Flow cytom-
etry analysis of yeast incubated with 50 nM BODIPY–cyclopamine
overnight at 30 C; left: YEpPMA-hSmo-MAP (grey line) and
YEpPMA-MAP (black line) transformed S. cerevisiae grown at
20 C until 2 OD600, right: PAO815-hSmo-MAP (grey line) and
PAO815-MAP (black line) transformed P. pastoris induced with
methanol during 24 h at 30 C. (B) Fluorescence variations of
BODIPY–cyclopamine bound to 200 lg of membrane preparations
from YEpPMA-hSmo-MAP transformed S. cerevisiae or PAO815-
hSmo-MAP transformed P. pastoris. Experiments were repeated three
times. F: ﬂuorescence intensity in the absence of cyclopamine. DF:
variation between ﬂuorescence intensity at diﬀerent concentrations of
cyclopamine and ﬂuorescence intensity without cyclopamine. Control
experiments have been carried out with membranes prepared from P.
pastoris or S. cerevisiae which do not express hSmo.
Fig. 5. HSmo puriﬁcation. 2 mg of P. pastoris membranes were
solubilised with 1% DDM in presence of 0.2% CHS and batch-loaded
on 100 ll of each aﬃnity resin: Ni–NTA, calmodulin and streptavidin,
2 h at 4 C. Membrane, solubilised and eluates were loaded on 10%
SDS–PAGE gel and immuno-detected with anti-Smo antibodies.
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and 2 times more ﬂuorescent than control yeast transformed
with empty vector. This indicates that at least part of hSmo ex-
pressed in both types of yeast is in a conformation allowing
cyclopamine binding (Fig. 3). The ﬂuorescence variations of
S. cerevisiae and P. pastoris membranes as a function of the
concentration of BODIPY–cyclopamine allowed to calculate
a half-eﬀect constant and a number of active hSmo per milli-
gram of membrane proteins of 0.02 nM and 100 pmol for S.
cerevisiae, and of 0.1 nM and 40 pmol for P. pastoris. We esti-
mate that hSmo in a correct conformation to bind cyclop-
amine represents about 1% of membrane proteins in S.
cerevisiae and 0.4% in P. pastoris, and that one liter of S. cere-
visiae or P. pastoris culture would contain 300 or 800 lg of
hSmo, respectively.
3.3. hSmo puriﬁcation
S. cerevisiae and P. pastoris membranes were solubilised
with 1% of diﬀerent detergents: lubrol, DDM, CHAPS, dode-
cyl glucoside, DDAO and C12E8, which critical micellar con-
centrations are comprised between 0.004% and 0.1%, and
analysed by Western blotting (Fig. 4). Since DDM is one of
the most eﬃcient detergents for hSmo solubilisation and one
of the most frequently used non-ionic detergents for puriﬁca-
tion and crystallisation of membrane proteins, it has been cho-
sen for hSmo puriﬁcation. In order to test the eﬃciency of the
diﬀerent aﬃnity resins for hSmo puriﬁcation, P. pastoris mem-
branes were solubilised with DDM in the presence of choleste-Fig. 4. hSmo solubilisation. 80 lg of membrane proteins prepared
from PAO815-hSmo-MAP transformed P. pastoris (A) or YEpPMA-
hSmo-MAP transformed S. cerevisiae (B) were solubilised with 1% of
the diﬀerent detergents, 1 h at 4 C, loaded on 10% SDS–PAGE gel
and immunoblotted with anti-Smo antibodies for P. pastoris and anti-
HA antibodies for S. cerevisiae.
Fig. 6. Silver-stained SDS-gel of Ni–NTA eluate.ryl hemisuccinate (CHS). As described for other human
GPCRs [28,31], addition of cholesterol derivative CHS to sol-
ubilisation experiments increases the stability of solubilised
hSmo. Therefore all puriﬁcation steps have been performed
in the presence of CHS. Same amounts of solubilised hSmo
have been incubated with Ni–NTA, calmodulin or streptavidin
resin in adequate buﬀers, and the Western-blotting analysis of
eluates indicates that Ni–NTA is the most eﬃcient resin
(Fig. 5). The eluate from Ni–NTA resin was loaded on SDS–
PAGE gel for silver-staining. The three bands that appear,
one at 80 kDa and two around 110 kDa, correspond to those
observed on the Western blot presented in Fig. 5 and represent
40% of total proteins loaded on gel (Fig. 6).4. Conclusion
This study shows that the human Hh signalling pathway
receptor Smo can be expressed in its native conformational
state, in glycosylated and mainly non-glycosylated forms, in
the membrane fraction of both types of yeast used as heterol-
ogous hosts: S. cerevisiae and P. pastoris. Smo is eﬃciently sol-
ubilised by dodecyl maltoside in the presence of cholesterol
derivative, and the protein fraction obtained after Ni–NTA
M. De Rivoyre et al. / FEBS Letters 579 (2005) 1529–1533 1533resin puriﬁcation contains 40% of hSmo. A second puriﬁcation
step using the calmodulin resin would allow the complete puri-
ﬁcation of hSmo. The expression levels reached in P. pastoris
are high enough to undertake large-scale production of hSmo
for structural studies.
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